Jesse A Columbo1,2, Pablo Martinez-Camblor3, A James O'Malley2,3, David H Stone1, Vikram S Kashyap4, Richard J Powell1, Marc L Schermerhorn5, Mahmoud Malas6, Brian W Nolan7, Philip P Goodney1,2. 1. Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. 2. Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire. 3. Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. 4. Vascular Center, Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio. 5. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. 6. Division of Vascular and Endovascular Surgery, University of California, San Diego Health, San Diego. 7. Section of Vascular Surgery, Maine Medical Center, Portland.
Abstract
Importance: Transcarotid artery revascularization (TCAR) may serve as a safer alternative to carotid endarterectomy (CEA) for certain patients with carotid artery stenosis. Objective: To determine the center-level association of TCAR adoption with overall perioperative outcomes for TCAR and CEA combined at centers performing both procedures. Design, Setting, and Participants: This comparative-effectiveness research was conducted with a difference-in-difference analysis using retrospective data from 2015 to 2019 from the Vascular Quality Initiative registry, a consortium of more than 400 centers in North America. Included patients underwent TCAR or CEA for carotid artery stenosis. Patients who underwent transfemoral carotid stenting were excluded. Data were analyzed from December 2019 through August 2020. Exposures: Center-level adoption of TCAR vs not. Main Outcomes and Measures: The rate of major adverse cardiovascular events (MACE), a composite of in-hospital stroke, myocardial infarction, or death at 30 days, was measured. Results: Among 86 027 patients who underwent revascularization for carotid artery stenosis, 7664 patients (8.9%) underwent TCAR (mean [SD] age, 73.1 [9.6] years; 2788 [36.4%] women; 6938 White patients [90.6%]; and 3741 patients with symptoms [48.8%]) and 78 363 patients (91.1%) underwent CEA (mean [SD] age, 70.6 [9.2] years; 30 928 [39.5%] women; 70 663 White patients [90.2%]; and 37 883 patients with symptoms [48.3%]). The number of centers performing both TCAR and CEA increased from 15 centers in 2015 to 247 centers in 2019, a more than 16-fold increase. The proportion of all carotid procedures that were TCARs increased from 90 of 12 276 (0.7%) in 2015 to 2718 of 15 956 (17.0%) in 2019, a 24-fold increase. Overall, the crude rate of MACE was similar for TCAR and CEA (178 patients [2.3%] after TCAR vs 1842 patients [2.4%] after CEA; P = .91). However, the rate of MACE over time decreased for CEA (406 of 16 404 patients [2.5%] in 2015 vs 189 of 10 097 patients [1.9%] in 2019; P for trend < .001). The rate of MACE over time decreased for TCAR as well, but the change was not statistically significant (4 of 128 patients [3.1%] in 2016 vs 59 of 2718 patients [2.2%] in 2019; P for trend = .07). Difference-in-difference analysis demonstrated that centers that adopted TCAR had a 10% decrease in the likelihood of MACE at 12 months after TCAR adoption vs if those centers had continued to perform CEA alone (odds ratio, 0.90; 95% CI, 0.81-0.99; P = .04). Conclusions and Relevance: This comparative-effectiveness study of a cohort of patients who underwent TCAR or CEA found that availability of TCAR at a hospital was associated with a decrease in the likelihood of perioperative MACE after carotid revascularization.
Importance: Transcarotid artery revascularization (TCAR) may serve as a safer alternative to carotid endarterectomy (CEA) for certain patients with carotid artery stenosis. Objective: To determine the center-level association of TCAR adoption with overall perioperative outcomes for TCAR and CEA combined at centers performing both procedures. Design, Setting, and Participants: This comparative-effectiveness research was conducted with a difference-in-difference analysis using retrospective data from 2015 to 2019 from the Vascular Quality Initiative registry, a consortium of more than 400 centers in North America. Included patients underwent TCAR or CEA for carotid artery stenosis. Patients who underwent transfemoral carotid stenting were excluded. Data were analyzed from December 2019 through August 2020. Exposures: Center-level adoption of TCAR vs not. Main Outcomes and Measures: The rate of major adverse cardiovascular events (MACE), a composite of in-hospital stroke, myocardial infarction, or death at 30 days, was measured. Results: Among 86 027 patients who underwent revascularization for carotid artery stenosis, 7664 patients (8.9%) underwent TCAR (mean [SD] age, 73.1 [9.6] years; 2788 [36.4%] women; 6938 White patients [90.6%]; and 3741 patients with symptoms [48.8%]) and 78 363 patients (91.1%) underwent CEA (mean [SD] age, 70.6 [9.2] years; 30 928 [39.5%] women; 70 663 White patients [90.2%]; and 37 883 patients with symptoms [48.3%]). The number of centers performing both TCAR and CEA increased from 15 centers in 2015 to 247 centers in 2019, a more than 16-fold increase. The proportion of all carotid procedures that were TCARs increased from 90 of 12 276 (0.7%) in 2015 to 2718 of 15 956 (17.0%) in 2019, a 24-fold increase. Overall, the crude rate of MACE was similar for TCAR and CEA (178 patients [2.3%] after TCAR vs 1842 patients [2.4%] after CEA; P = .91). However, the rate of MACE over time decreased for CEA (406 of 16 404 patients [2.5%] in 2015 vs 189 of 10 097 patients [1.9%] in 2019; P for trend < .001). The rate of MACE over time decreased for TCAR as well, but the change was not statistically significant (4 of 128 patients [3.1%] in 2016 vs 59 of 2718 patients [2.2%] in 2019; P for trend = .07). Difference-in-difference analysis demonstrated that centers that adopted TCAR had a 10% decrease in the likelihood of MACE at 12 months after TCAR adoption vs if those centers had continued to perform CEA alone (odds ratio, 0.90; 95% CI, 0.81-0.99; P = .04). Conclusions and Relevance: This comparative-effectiveness study of a cohort of patients who underwent TCAR or CEA found that availability of TCAR at a hospital was associated with a decrease in the likelihood of perioperative MACE after carotid revascularization.
Authors: Marc L Schermerhorn; Patric Liang; Hanaa Dakour-Aridi; Vikram S Kashyap; Grace J Wang; Brian W Nolan; Jack L Cronenwett; Jens Eldrup-Jorgensen; Mahmoud B Malas Journal: J Vasc Surg Date: 2019-06-18 Impact factor: 4.268
Authors: Mahmoud B Malas; Jose Leal; Vikram Kashyap; Richard Paul Cambria; Christopher J Kwolek; Enrique Criado Journal: J Vasc Surg Date: 2017-03 Impact factor: 4.268
Authors: Michael J Mack; Martin B Leon; Vinod H Thourani; Raj Makkar; Susheel K Kodali; Mark Russo; Samir R Kapadia; S Chris Malaisrie; David J Cohen; Philippe Pibarot; Jonathon Leipsic; Rebecca T Hahn; Philipp Blanke; Mathew R Williams; James M McCabe; David L Brown; Vasilis Babaliaros; Scott Goldman; Wilson Y Szeto; Philippe Genereux; Ashish Pershad; Stuart J Pocock; Maria C Alu; John G Webb; Craig R Smith Journal: N Engl J Med Date: 2019-03-16 Impact factor: 91.245
Authors: Mahmoud B Malas; Hanaa Dakour-Aridi; Grace J Wang; Vikram S Kashyap; Raghu L Motaganahalli; Jens Eldrup-Jorgensen; Jack L Cronenwett; Marc L Schermerhorn Journal: J Vasc Surg Date: 2018-06-22 Impact factor: 4.268
Authors: Christopher J Kwolek; Michael R Jaff; J Ignacio Leal; L Nelson Hopkins; Rasesh M Shah; Todd M Hanover; Sumaira Macdonald; Richard P Cambria Journal: J Vasc Surg Date: 2015-11 Impact factor: 4.268
Authors: Jesse A Columbo; Robert M Zwolak; Edward J Arous; Philip P Goodney; Michael P Lilly; H Gilbert Welch Journal: Circulation Date: 2020-01-16 Impact factor: 29.690
Authors: Vikram S Kashyap; Alexander H King; Patric Liang; Jens Eldrup-Jorgensen; Grace J Wang; Mahmoud B Malas; Brian W Nolan; Jack L Cronenwett; Marc L Schermerhorn Journal: J Am Coll Surg Date: 2019-10-28 Impact factor: 6.113
Authors: Godly Jack; Sameer Arora; Paula D Strassle; Kranthi Sitammagari; Kishorbhai Gangani; Michael Yeung; Matthew A Cavender; Patrick T O'Gara; John P Vavalle Journal: J Am Heart Assoc Date: 2019-11-13 Impact factor: 5.501
Authors: George Q Zhang; Sanuja Bose; David P Stonko; Christopher J Abularrage; Devin S Zarkowsky; Caitlin W Hicks Journal: J Vasc Surg Date: 2022-03-31 Impact factor: 4.860